These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7439241)
1. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol. Folgering H; van Bussel M Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system. Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440 [TBL] [Abstract][Full Text] [Related]
3. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol. Folgering HT; Borm JF; van Haaren RH Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299 [TBL] [Abstract][Full Text] [Related]
4. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750 [TBL] [Abstract][Full Text] [Related]
5. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules. Asplund J; Ohman P Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891 [TBL] [Abstract][Full Text] [Related]
6. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Kendall MJ; John VA; Quarterman CP; Welling PG Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709 [TBL] [Abstract][Full Text] [Related]
7. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers. Mucklow JC; Kuhn S Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension. Lund-Johansen P; Ohm OJ Br J Clin Pharmacol; 1977 Apr; 4(2):147-51. PubMed ID: 861129 [TBL] [Abstract][Full Text] [Related]
9. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets. Rydén L; Kristensson BE; Westergren G Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392 [TBL] [Abstract][Full Text] [Related]
10. A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol. Nievel JG; Harvard CW Curr Med Res Opin; 1981; 7(8):503-15. PubMed ID: 7030636 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation. Quaterman CP; Kendall MJ; Welling PG Eur J Clin Pharmacol; 1979 Mar; 15(2):97-103. PubMed ID: 436924 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation. Oosterhuis B; Jonkman JH; Kerkhof FA Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389 [TBL] [Abstract][Full Text] [Related]
14. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers. van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028 [TBL] [Abstract][Full Text] [Related]
15. Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol. van Baak M; Jennen W; Verstappen FT Eur J Clin Pharmacol; 1985; 28(2):143-8. PubMed ID: 3987795 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA). Harron DW; Shanks RG Br J Clin Pharmacol; 1981 May; 11(5):518-20. PubMed ID: 7272165 [No Abstract] [Full Text] [Related]
17. Effects of acute and chronic metoprolol administration during submaximal and maximal exercise. van Baak MA; Jennen W; Muijtjens A; Verstappen FT Int J Sports Med; 1985 Dec; 6(6):347-52. PubMed ID: 4077364 [TBL] [Abstract][Full Text] [Related]
18. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates. Warrington SJ; Barclay SP; John VA; Shotton PA; Good W Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127 [TBL] [Abstract][Full Text] [Related]
19. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients. van Herwaarden CL; Binkhorst RA; Fennis JF; van't Laar A Br Heart J; 1979 Jan; 41(1):99-105. PubMed ID: 371643 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]